Journal of Biomolecular Screening

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1087057106291541v1
11/7/765    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moger, J.
Right arrow Articles by Winlove, C. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moger, J.
Right arrow Articles by Winlove, C. P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
This version was published on October 1, 2006
Journal of Biomolecular Screening, Vol. 11, No. 7, 765-772 (2006)
DOI: 10.1177/1087057106291541

The Application of Fluorescence Lifetime Readouts in High-Throughput Screening

Julian Moger

School of Physics, University of Exeter, Exeter, UK

Philip Gribbon

Pfizer Global Research and Development, Sandwich Laboratories, Sandwich, Kent, UK, GlaxoSmithKline Research and Development Limited, Medicines’ Research Centre, Stevenage, Herts, UK

Andreas Sewing

Pfizer Global Research and Development, Sandwich Laboratories, Sandwich, Kent, UK

C. Peter Winlove

School of Physics, University of Exeter, Exeter, UK

Measurement of fluorescence lifetime is a well-established technique, which has recently been introduced into the portfolio of assay formats used in high-throughput screening (HTS). This investigation establishes appropriate conditions for using lifetime measurements to reduce the impact of compound interference effects during large-scale HTS of corporate screening files. Experimental data on mixtures of standard fluorophores and interfering compounds (from 5 HTS campaigns) have been combined with a theoretical model to identify the minimum data quality required, defined by the photon count in the peak channel, for discrimination of biological activity. Single-component fluorophore lifetimes can be recovered with an error of 1%, with a peak photon count of 102, but the same accuracy with a 2-component decay requires a peak photon count of 103. When a 3rd component is introduced, the minimum peak count increases to 104. The influence of scattered light on lifetime determination was investigated using an emulsion (diameters 25-675 nm). The measured decays of interfering compounds, identified as autofluorescent, show that the vast majority have a very short lifetime that can readily be resolved from the reporter fluorophore, using appropriate data-fitting methods.

Key Words: high-throughput screening • fluorescence lifetime • FIDA • fluorescence polarization


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J Biomol ScreenHome page
C. S. Lebakken, Hee Chol Kang, and K. W. Vogel
A Fluorescence Lifetime Based Binding Assay to Characterize Kinase Inhibitors
J Biomol Screen, September 1, 2007; 12(6): 828 - 841.
[Abstract] [PDF]